Document is current
Any future updates will be listed below
-
Authors
Butt, Adeel A.
Shams, Sherin
Jabeen, Atika
Al-Nuaimi, Asma Ali
Krishnan, Jeyaram Illiayaraja
Malik, Aimon B.
Saleem, Samah
Abdulaziz, Maryam Hassan
Seyam, Naheel Ismail
Aziz, Kamran
Kandil, Dalia
Thomas, Anil G.
Nafady-Hego, Hanaa
Lone, Muzna I.
Al Ajmi, Jameela
Bhutta, Zain A.
AlSulaiti, Noora
Hussein, Wael E. Said
Semaan, Sandy
Al-Abdulla, Samya Ahmad
Al-Kuwari, Mohamed Ghaith
Abou-Samra, Abdul-Badi
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 4 June 2025
First Online: 1 July 2025
Declarations
:
: The study was approved by the Institutional Review Boards at Hamad Medical Corporation (MRC-01–23-076) and the Primary Health Care Corporation (BUHOOTH-D-23–00050). A waiver of the informed consent requirement was granted by both Institutional Review Boards (Hamad medical Corporation and the Primary Healthcare Corporation through the aforementioned project numbers) since no individual level interactions or interventions were proposed. This research study adhered to the ethical guidelines outlined in the Declaration of Helsinki. The study was registered with ClinicalTrials.gov (ID: NCT06135376) prior to the commencement of the study.
: Not applicable.
: Dr. Butt has received investigator initiated grant funding from Gilead Sciences and Merck and Company (to the institution, Veterans Health Foundation of Pittsburgh) which are unrelated to the work presented here. Other authors declare no financial conflict of interest regarding the content of this article.
